SCHEMBL18636768

SCHEMBL18636768

CC(C)(C)OC(=O)N1CCC[C@@H]2CN(c3cc(Cl)nc(N)n3)CC21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
AURKA O14965 3/20 0.39
PDPK1 O15530 3/20 0.39
AURKB Q96GD4 3/20 0.39
HRH4 Q9H3N8 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.37
USP30 Q70CQ3 1/20 0.37
KMT2A Q03164 1/20 0.36
GPR119 Q8TDV5 2/20 0.36
MAP4K4 O95819 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18636767 1.00 LMNA (0.47) LMNANR1H2NR1H3HSP90AA1HSP90AB1
SCHEMBL12604962 1.00 LMNA (0.47) LMNANR1H2NR1H3HSP90AA1HSP90AB1
SCHEMBL3211110 0.87 HRH4 (0.54) NR1H2NR1H3HRH4
SCHEMBL5152986 0.84 LMNA (0.48) LMNAHRH4CYP1A2CYP2D6MAPT
SCHEMBL5152980 0.84 LMNA (0.48) LMNAHRH4CYP1A2CYP2D6MAPT
SCHEMBL18636601 0.82 HRH4 (0.54) NR1H2NR1H3AURKAPDPK1AURKB
SCHEMBL12604978 0.82 HRH4 (0.54) NR1H2NR1H3AURKAPDPK1AURKB
SCHEMBL23855422 0.81 PIK3CD (0.38) LMNANR1H2NR1H3AURKAPDPK1
SCHEMBL653782 0.76 NR1H2 (0.48) NR1H2NR1H3ALDH1A1GPR119RET
SCHEMBL653780 0.76 NR1H2 (0.48) NR1H2NR1H3ALDH1A1GPR119RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966162-B1 PYRIMIDINE DERIVATIVES ZIARCO PHARMA LTD (GB) 2017-03-15 EP disclosed